| Home > Authorities > Experiments > Record #257441 |
ESMI
European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative
| Operating body | Deutsches Zentrum für Neurodegenerative Erkrankungen |
| Categories | Experiment |
| Further information: | Website |
| Identifier | EXP:(DE-2719)ESMI-20140101 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Cognitive impairment in SCA3: A multi-center cohort study with demographic, imaging, and biomarker correlates.
Neurobiology of disease 220, 107301 (2026) [10.1016/j.nbd.2026.107301]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Brain atrophy staging in spinocerebellar ataxia type 3 for clinical prognosis and trial enrichment.
EBioMedicine 123, 106090 (2026) [10.1016/j.ebiom.2025.106090]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Longitudinal description of health-related quality of life and depressive symptoms in polyQ spinocerebellar ataxia patients.
Journal of neurology 272(5), 323 (2025) [10.1007/s00415-025-13024-0]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood.
Movement disorders 36(11), 2675 - 2681 (2021) [10.1002/mds.28749]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3.
Movement disorders 36(10), 2273-2281 (2021) [10.1002/mds.28610]
Files
Fulltext
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
EMBO molecular medicine 12(7), e11803 (2020) [10.15252/emmm.201911803]
Files
Fulltext
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |